Published in Oncogene on March 18, 2004
GADD45A does not promote DNA demethylation. PLoS Genet (2008) 2.36
Epigenetic alterations in human prostate cancers. Endocrinology (2009) 1.55
DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Rev Mol Diagn (2009) 1.08
Promoter hypermethylation in prostate cancer. Cancer Control (2010) 0.99
Aberrant DNA methylation and prostate cancer. Curr Genomics (2011) 0.98
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines. BMC Cancer (2010) 0.94
Epigenetics in prostate cancer. Prostate Cancer (2011) 0.92
DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol (2012) 0.88
Mitogen Activated Protein kinase signal transduction pathways in the prostate. Cell Commun Signal (2004) 0.87
Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding. PLoS One (2012) 0.86
Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN. Oncogenesis (2013) 0.84
G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells. BMC Cancer (2011) 0.84
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth. PLoS One (2012) 0.84
Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate Cancer. Chin J Cancer Res (2011) 0.84
The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis. PLoS One (2013) 0.81
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS One (2015) 0.79
Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth. J Biomed Sci (2011) 0.79
Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Oncol Rep (2015) 0.77
Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action. Dermatoendocrinol (2009) 0.76
Tazarotene-Induced Gene 1 Enhanced Cervical Cell Autophagy through Transmembrane Protein 192. Mol Cells (2016) 0.75
Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73. Oncogene (2015) 0.75
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature (2011) 6.73
Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci U S A (2011) 5.45
Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res (2010) 4.79
A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci U S A (2009) 4.72
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res (2006) 3.66
Protection from experimental asthma by an endogenous bronchodilator. Science (2005) 3.17
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91
Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res (2011) 2.53
The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta (2009) 2.50
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res (2011) 2.36
GADD45A does not promote DNA demethylation. PLoS Genet (2008) 2.36
A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell (2008) 2.28
Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab Invest (2005) 2.23
Repair of methylation damage in DNA and RNA by mammalian AlkB homologues. J Biol Chem (2005) 2.19
S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med (2010) 2.13
Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep (2013) 2.10
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A (2007) 2.10
The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem (2006) 2.10
Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res (2008) 2.08
Tumor susceptibility of Rassf1a knockout mice. Cancer Res (2005) 2.03
Insulin gene expression is regulated by DNA methylation. PLoS One (2009) 1.97
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene (2002) 1.96
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol (2007) 1.91
Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol (2004) 1.81
Enzymes that counteract nitrosative stress promote fungal virulence. Curr Biol (2003) 1.75
Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol Ther (2005) 1.67
Maintenance of nitric oxide and redox homeostasis by the salmonella flavohemoglobin hmp. J Biol Chem (2006) 1.58
The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell (2005) 1.58
CpG island hypermethylation in human astrocytomas. Cancer Res (2010) 1.57
Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene (2003) 1.54
Clinical outcomes of two different types of open-door laminoplasties for cervical compressive myelopathy: a prospective study. Neurol India (2012) 1.53
Anterior decompression and nonstructural bone grafting and posterior fixation for cervical facet dislocation with traumatic disc herniation. Spine (Phila Pa 1976) (2012) 1.51
Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PLoS One (2011) 1.50
Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst (2003) 1.48
Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res (2003) 1.48
Methylation of the RASSF1A gene in human cancers. Biol Chem (2002) 1.47
Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant (2012) 1.46
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet (2010) 1.44
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog (2007) 1.44
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res (2009) 1.43
In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology (2009) 1.43
MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex. J Biol Chem (2004) 1.41
Two-stage vertebral column resection for severe and rigid scoliosis in patients with low body weight. Spine J (2012) 1.39
The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein. Cell Cycle (2005) 1.37
The MIRA method for DNA methylation analysis. Methods Mol Biol (2009) 1.35
DNA methylation biomarkers for lung cancer. Tumour Biol (2011) 1.35
Epigenetic control of female puberty. Nat Neurosci (2013) 1.34
Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming. Genome Biol (2015) 1.30
DNA methylation profiling using the methylated-CpG island recovery assay (MIRA). Methods (2010) 1.30
RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene (2002) 1.29
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene (2003) 1.27
A genetic analysis of nitrosative stress. Biochemistry (2009) 1.25
Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene (2002) 1.23
Microcephalin encodes a centrosomal protein. Cell Cycle (2006) 1.21
Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG-->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells. Nucleic Acids Res (2002) 1.21
Screening for nitric oxide-dependent protein-protein interactions. Science (2003) 1.20
The role of DNA polymerase eta in UV mutational spectra. DNA Repair (Amst) (2005) 1.20
Second-hand smoke and human lung cancer. Lancet Oncol (2008) 1.17
Hemivertebrae resection for unbalanced multiple hemivertebrae: is it worth it? Eur Spine J (2013) 1.16
Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene (2003) 1.15
DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci U S A (2005) 1.15
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res (2002) 1.15
Aging and DNA methylation. BMC Biol (2015) 1.15
A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer (2010) 1.14
Regulation of T cell priming by lymphoid stroma. PLoS One (2011) 1.14
Human thymine DNA glycosylase (TDG) and methyl-CpG-binding protein 4 (MBD4) excise thymine glycol (Tg) from a Tg:G mispair. Nucleic Acids Res (2003) 1.14
Tet-mediated formation of 5-hydroxymethylcytosine in RNA. J Am Chem Soc (2014) 1.14
The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem (2004) 1.13
Human RIF1 encodes an anti-apoptotic factor required for DNA repair. Carcinogenesis (2009) 1.12
Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis (2005) 1.11
Chromosome-wide analysis of parental allele-specific chromatin and DNA methylation. Mol Cell Biol (2011) 1.11
Gene expression profiling of tumor xenografts: In vivo analysis of organ-specific metastasis. Int J Cancer (2003) 1.10
Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res (2008) 1.10
A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis (2007) 1.10
Translesion synthesis of 7,8-dihydro-8-oxo-2'-deoxyguanosine by DNA polymerase eta in vivo. Mutat Res (2008) 1.09
The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J Biol Chem (2011) 1.09
Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res (2005) 1.09
Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol (2011) 1.08
Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis. J Biol Chem (2003) 1.08
CTCF-dependent chromatin bias constitutes transient epigenetic memory of the mother at the H19-Igf2 imprinting control region in prospermatogonia. PLoS Genet (2010) 1.07
Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer (2010) 1.07
53BP1 is a positive regulator of the BRCA1 promoter. Cell Cycle (2005) 1.06
Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencing. PLoS One (2010) 1.06
Lymphocyte development requires S-nitrosoglutathione reductase. J Immunol (2010) 1.05
G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells. Biochemistry (2004) 1.05
A methylation profile of in vitro immortalized human cell lines. Int J Oncol (2005) 1.04
Fine tuning of globin gene expression by DNA methylation. PLoS One (2006) 1.04
Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res (2003) 1.04
MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor. Genomics (2002) 1.04
Effect of Mini-plate Fixation on Hinge Fracture and Bony Fusion in Unilateral Open-door Cervical Expansive Laminoplasty. Clin Spine Surg (2016) 1.01
GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenet Genomics (2010) 1.00
The role of DNA polymerase iota in UV mutational spectra. Mutat Res (2006) 0.99
Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res (2006) 0.99